CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
3 hedge funds and large institutions have $948K invested in Loncar China BioPharma ETF in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-4
Holders Change %
-57.14%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Jane Street
New York
|
-$888K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$45K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$25.8K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$11K |
| 5 |
Citigroup
New York
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $876K | -$888K | -28,891 | -50% |
|
2
Morgan Stanley
New York
| $61K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $11K | -$25.8K | -805 | -70% |
|
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$45K | -2,000 | Closed |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| – | -$11K | -500 | Closed |
|
|
6
Citigroup
New York
| – | -$9K | -390 | Closed |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -100 | Closed |
|